Stay updated on BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page shows a new revision tag, updating from v3.6.4 to v3.6.5, indicating a minor page revision. This change does not affect any study details or visible content related to the trial.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe revision label on the page was updated from v3.6.3 to v3.6.4. This represents a minor metadata update with no change to the study content shown.SummaryDifference0.0%

- Check51 days agoChange Detected- Revision tag updated from v3.6.0 to v3.6.3, indicating a small update to the study record metadata on the page. This reflects a minor revision to the page's versioning rather than substantive content changes.SummaryDifference0.0%

- Check65 days agoChange DetectedRecruitment status updated to indicate no enrollment; new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, the Intervention/Treatment label was standardized, and the revision tag updated to v3.6.0.SummaryDifference0.3%

- Check72 days agoChange DetectedThe page's revision label updates from v3.5.4 to v3.5.5, signaling a small update to the site's revision history.SummaryDifference0.0%

- Check93 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 for the study record, indicating a metadata/version change in the COMBAT entry. This update does not modify the study content or eligibility details.SummaryDifference0.0%

Stay in the know with updates to BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page.